Bronchodilators Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Indication (Asthma, COPD, Others); Drug Type (Sympathomimetics, Anticholinergics, Phosphodiesterase Inhibitor, Combination Drugs); Route of Administration (Oral, Injection, Inhaler) and Geography

Report Code: TIPRE00018973 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Bronchodilators are the agents that are used to make breathing easier by widening of bronchi and relaxing muscles of lungs. Bronchodilators are used to treat various short and long term airway disorders in which the airway gets inflamed and narrow. The bronchodilators are also used a mucolytic agents. Bronchodilators are commonly used in conditions like chronic obstructive pulmonary disease and asthma. Bronchodilators are of two categories one is the short acting bronchodilators and another is long term acting bronchodilators.

MARKET DYNAMICS

The key market drivers for Bronchodilators Market are, high prevalence of respiratory disorders such as COPD, cystic fibrosis, asthma across the globe along with growing ageing population. Moreover, rising awareness about healthcare among people and ongoing R&D activities for development of novel bronchodilators are also expected to boost market growth during forecast period. Whereas, side effects associated with prolonged use of bronchodilators are expected to restrain market growth during forecast period.

MARKET SCOPE

The "Bronchodilators Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Bronchodilators market with detailed market segmentation by indication, drug type and route of administration. The Bronchodilators Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Bronchodilators Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Bronchodilators Market is segmented on the basis of indication, drug type and route of administration. On the basis of indication the market is segmented as, asthma, COPD, others. On the basis of drug type the market is segmented as, sympathomimetics, anticholinergics, phosphodiesterase inhibitor and combination drugs. And on the basis of route of administration the market is bifurcated as, oral, injection and inhaler.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Bronchodilators Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Bronchodilators Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Bronchodilators Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Bronchodilators Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Bronchodilators Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Bronchodilators Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Bronchodilators market in the global market. Below mentioned is the list of few companies engaged in the Bronchodilators Market.

The report also includes the profiles of key players in Bronchodilators Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Boehringer Ingelheim
  •   GlaxoSmithKline
  •   F. Hoffmann-La Roche AG
  •   AstraZeneca Plc.
  •   Pfizer, Inc.
  •   Teva Pharmaceutical Industries Ltd.
  •   Vectura Group plc.
  •   Novartis AG
  •   Abbott Laboratories
  •   Gilead Sciences

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bronchodilators Market - By Indication
1.3.2 Bronchodilators Market - By Drug Type
1.3.3 Bronchodilators Market - By Route of Administration
1.3.4 Bronchodilators Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BRONCHODILATORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BRONCHODILATORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BRONCHODILATORS MARKET - GLOBAL MARKET ANALYSIS
6.1. BRONCHODILATORS - GLOBAL MARKET OVERVIEW
6.2. BRONCHODILATORS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. BRONCHODILATORS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. ASTHMA
7.3.1. Overview
7.3.2. Asthma Market Forecast and Analysis
7.4. COPD
7.4.1. Overview
7.4.2. COPD Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. BRONCHODILATORS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. SYMPATHOMIMETICS
8.3.1. Overview
8.3.2. Sympathomimetics Market Forecast and Analysis
8.4. ANTICHOLINERGICS
8.4.1. Overview
8.4.2. Anticholinergics Market Forecast and Analysis
8.5. PHOSPHODIESTERASE INHIBITOR
8.5.1. Overview
8.5.2. Phosphodiesterase Inhibitor Market Forecast and Analysis
8.6. COMBINATION DRUGS
8.6.1. Overview
8.6.2. Combination Drugs Market Forecast and Analysis
9. BRONCHODILATORS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INJECTION
9.4.1. Overview
9.4.2. Injection Market Forecast and Analysis
9.5. INHALER
9.5.1. Overview
9.5.2. Inhaler Market Forecast and Analysis

10. BRONCHODILATORS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Bronchodilators Market Overview
10.1.2 North America Bronchodilators Market Forecasts and Analysis
10.1.3 North America Bronchodilators Market Forecasts and Analysis - By Indication
10.1.4 North America Bronchodilators Market Forecasts and Analysis - By Drug Type
10.1.5 North America Bronchodilators Market Forecasts and Analysis - By Route of Administration
10.1.6 North America Bronchodilators Market Forecasts and Analysis - By Countries
10.1.6.1 United States Bronchodilators Market
10.1.6.1.1 United States Bronchodilators Market by Indication
10.1.6.1.2 United States Bronchodilators Market by Drug Type
10.1.6.1.3 United States Bronchodilators Market by Route of Administration
10.1.6.2 Canada Bronchodilators Market
10.1.6.2.1 Canada Bronchodilators Market by Indication
10.1.6.2.2 Canada Bronchodilators Market by Drug Type
10.1.6.2.3 Canada Bronchodilators Market by Route of Administration
10.1.6.3 Mexico Bronchodilators Market
10.1.6.3.1 Mexico Bronchodilators Market by Indication
10.1.6.3.2 Mexico Bronchodilators Market by Drug Type
10.1.6.3.3 Mexico Bronchodilators Market by Route of Administration
10.2. EUROPE
10.2.1 Europe Bronchodilators Market Overview
10.2.2 Europe Bronchodilators Market Forecasts and Analysis
10.2.3 Europe Bronchodilators Market Forecasts and Analysis - By Indication
10.2.4 Europe Bronchodilators Market Forecasts and Analysis - By Drug Type
10.2.5 Europe Bronchodilators Market Forecasts and Analysis - By Route of Administration
10.2.6 Europe Bronchodilators Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Bronchodilators Market
10.2.6.1.1 Germany Bronchodilators Market by Indication
10.2.6.1.2 Germany Bronchodilators Market by Drug Type
10.2.6.1.3 Germany Bronchodilators Market by Route of Administration
10.2.6.2 France Bronchodilators Market
10.2.6.2.1 France Bronchodilators Market by Indication
10.2.6.2.2 France Bronchodilators Market by Drug Type
10.2.6.2.3 France Bronchodilators Market by Route of Administration
10.2.6.3 Italy Bronchodilators Market
10.2.6.3.1 Italy Bronchodilators Market by Indication
10.2.6.3.2 Italy Bronchodilators Market by Drug Type
10.2.6.3.3 Italy Bronchodilators Market by Route of Administration
10.2.6.4 Spain Bronchodilators Market
10.2.6.4.1 Spain Bronchodilators Market by Indication
10.2.6.4.2 Spain Bronchodilators Market by Drug Type
10.2.6.4.3 Spain Bronchodilators Market by Route of Administration
10.2.6.5 United Kingdom Bronchodilators Market
10.2.6.5.1 United Kingdom Bronchodilators Market by Indication
10.2.6.5.2 United Kingdom Bronchodilators Market by Drug Type
10.2.6.5.3 United Kingdom Bronchodilators Market by Route of Administration
10.2.6.6 Rest of Europe Bronchodilators Market
10.2.6.6.1 Rest of Europe Bronchodilators Market by Indication
10.2.6.6.2 Rest of Europe Bronchodilators Market by Drug Type
10.2.6.6.3 Rest of Europe Bronchodilators Market by Route of Administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Bronchodilators Market Overview
10.3.2 Asia-Pacific Bronchodilators Market Forecasts and Analysis
10.3.3 Asia-Pacific Bronchodilators Market Forecasts and Analysis - By Indication
10.3.4 Asia-Pacific Bronchodilators Market Forecasts and Analysis - By Drug Type
10.3.5 Asia-Pacific Bronchodilators Market Forecasts and Analysis - By Route of Administration
10.3.6 Asia-Pacific Bronchodilators Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Bronchodilators Market
10.3.6.1.1 Australia Bronchodilators Market by Indication
10.3.6.1.2 Australia Bronchodilators Market by Drug Type
10.3.6.1.3 Australia Bronchodilators Market by Route of Administration
10.3.6.2 China Bronchodilators Market
10.3.6.2.1 China Bronchodilators Market by Indication
10.3.6.2.2 China Bronchodilators Market by Drug Type
10.3.6.2.3 China Bronchodilators Market by Route of Administration
10.3.6.3 India Bronchodilators Market
10.3.6.3.1 India Bronchodilators Market by Indication
10.3.6.3.2 India Bronchodilators Market by Drug Type
10.3.6.3.3 India Bronchodilators Market by Route of Administration
10.3.6.4 Japan Bronchodilators Market
10.3.6.4.1 Japan Bronchodilators Market by Indication
10.3.6.4.2 Japan Bronchodilators Market by Drug Type
10.3.6.4.3 Japan Bronchodilators Market by Route of Administration
10.3.6.5 South Korea Bronchodilators Market
10.3.6.5.1 South Korea Bronchodilators Market by Indication
10.3.6.5.2 South Korea Bronchodilators Market by Drug Type
10.3.6.5.3 South Korea Bronchodilators Market by Route of Administration
10.3.6.6 Rest of Asia-Pacific Bronchodilators Market
10.3.6.6.1 Rest of Asia-Pacific Bronchodilators Market by Indication
10.3.6.6.2 Rest of Asia-Pacific Bronchodilators Market by Drug Type
10.3.6.6.3 Rest of Asia-Pacific Bronchodilators Market by Route of Administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Bronchodilators Market Overview
10.4.2 Middle East and Africa Bronchodilators Market Forecasts and Analysis
10.4.3 Middle East and Africa Bronchodilators Market Forecasts and Analysis - By Indication
10.4.4 Middle East and Africa Bronchodilators Market Forecasts and Analysis - By Drug Type
10.4.5 Middle East and Africa Bronchodilators Market Forecasts and Analysis - By Route of Administration
10.4.6 Middle East and Africa Bronchodilators Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Bronchodilators Market
10.4.6.1.1 South Africa Bronchodilators Market by Indication
10.4.6.1.2 South Africa Bronchodilators Market by Drug Type
10.4.6.1.3 South Africa Bronchodilators Market by Route of Administration
10.4.6.2 Saudi Arabia Bronchodilators Market
10.4.6.2.1 Saudi Arabia Bronchodilators Market by Indication
10.4.6.2.2 Saudi Arabia Bronchodilators Market by Drug Type
10.4.6.2.3 Saudi Arabia Bronchodilators Market by Route of Administration
10.4.6.3 U.A.E Bronchodilators Market
10.4.6.3.1 U.A.E Bronchodilators Market by Indication
10.4.6.3.2 U.A.E Bronchodilators Market by Drug Type
10.4.6.3.3 U.A.E Bronchodilators Market by Route of Administration
10.4.6.4 Rest of Middle East and Africa Bronchodilators Market
10.4.6.4.1 Rest of Middle East and Africa Bronchodilators Market by Indication
10.4.6.4.2 Rest of Middle East and Africa Bronchodilators Market by Drug Type
10.4.6.4.3 Rest of Middle East and Africa Bronchodilators Market by Route of Administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Bronchodilators Market Overview
10.5.2 South and Central America Bronchodilators Market Forecasts and Analysis
10.5.3 South and Central America Bronchodilators Market Forecasts and Analysis - By Indication
10.5.4 South and Central America Bronchodilators Market Forecasts and Analysis - By Drug Type
10.5.5 South and Central America Bronchodilators Market Forecasts and Analysis - By Route of Administration
10.5.6 South and Central America Bronchodilators Market Forecasts and Analysis - By Countries
10.5.6.1 Argentina Bronchodilators Market
10.5.6.1.1 Argentina Bronchodilators Market by Indication
10.5.6.1.2 Argentina Bronchodilators Market by Drug Type
10.5.6.1.3 Argentina Bronchodilators Market by Route of Administration
10.5.6.2 Rest of South and Central America Bronchodilators Market
10.5.6.2.1 Rest of South and Central America Bronchodilators Market by Indication
10.5.6.2.2 Rest of South and Central America Bronchodilators Market by Drug Type
10.5.6.2.3 Rest of South and Central America Bronchodilators Market by Route of Administration

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BRONCHODILATORS MARKET, KEY COMPANY PROFILES
12.1. BOEHRINGER INGELHEIM
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVARTIS AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PFIZER INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. VECTURA GROUP PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ABBOTT LABORATORIES
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GILEAD SCIENCES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Boehringer Ingelheim
2. GlaxoSmithKline
3. F. Hoffmann-La Roche AG
4. AstraZeneca plc
5. Novartis AG
6. Pfizer Inc
7. Teva Pharmaceutical Industries Ltd
8. Vectura Group plc
9. Abbott Laboratories
10. Gilead Sciences
TIPRE00018973
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking